These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24714201)

  • 1. Colocalization of cell death with antigen deposition in skin enhances vaccine immunogenicity.
    Depelsenaire ACI; Meliga SC; McNeilly CL; Pearson FE; Coffey JW; Haigh OL; Flaim CJ; Frazer IH; Kendall MAF
    J Invest Dermatol; 2014 Sep; 134(9):2361-2370. PubMed ID: 24714201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses.
    Fernando GJ; Chen X; Primiero CA; Yukiko SR; Fairmaid EJ; Corbett HJ; Frazer IH; Brown LE; Kendall MA
    J Control Release; 2012 Apr; 159(2):215-21. PubMed ID: 22306334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza nucleoprotein DNA vaccination by a skin targeted, dry coated, densely packed microprojection array (Nanopatch) induces potent antibody and CD8(+) T cell responses.
    Fernando GJ; Zhang J; Ng HI; Haigh OL; Yukiko SR; Kendall MA
    J Control Release; 2016 Sep; 237():35-41. PubMed ID: 27381247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microneedle-based vaccines.
    Prausnitz MR; Mikszta JA; Cormier M; Andrianov AK
    Curr Top Microbiol Immunol; 2009; 333():369-93. PubMed ID: 19768415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional anti-polysaccharide IgG titres induced by unadjuvanted pneumococcal-conjugate vaccine when delivered by microprojection-based skin patch.
    Pearson FE; Muller DA; Roalfe L; Zancolli M; Goldblatt D; Kendall MA
    Vaccine; 2015 Nov; 33(48):6675-83. PubMed ID: 26518398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice.
    Song JM; Kim YC; Lipatov AS; Pearton M; Davis CT; Yoo DG; Park KM; Chen LM; Quan FS; Birchall JC; Donis RO; Prausnitz MR; Compans RW; Kang SM
    Clin Vaccine Immunol; 2010 Sep; 17(9):1381-9. PubMed ID: 20631330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™).
    Fernando GJP; Hickling J; Jayashi Flores CM; Griffin P; Anderson CD; Skinner SR; Davies C; Witham K; Pryor M; Bodle J; Rockman S; Frazer IH; Forster AH
    Vaccine; 2018 Jun; 36(26):3779-3788. PubMed ID: 29779922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin.
    Quan FS; Kim YC; Yoo DG; Compans RW; Prausnitz MR; Kang SM
    PLoS One; 2009 Sep; 4(9):e7152. PubMed ID: 19779615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
    Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
    Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient antigen delivery to the draining lymph nodes is a key component in the immunogenic pathway of the intradermal vaccine.
    Tozuka M; Oka T; Jounai N; Egawa G; Ishii KJ; Kabashima K; Takeshita F
    J Dermatol Sci; 2016 Apr; 82(1):38-45. PubMed ID: 26674124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine.
    Weldon WC; Zarnitsyn VG; Esser ES; Taherbhai MT; Koutsonanos DG; Vassilieva EV; Skountzou I; Prausnitz MR; Compans RW
    PLoS One; 2012; 7(7):e41501. PubMed ID: 22848514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable microneedles with an immune-boosting function for effective intradermal influenza vaccination.
    Chen YH; Lai KY; Chiu YH; Wu YW; Shiau AL; Chen MC
    Acta Biomater; 2019 Oct; 97():230-238. PubMed ID: 31362139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent response of QS-21 as a vaccine adjuvant in the skin when delivered with the Nanopatch, resulted in adjuvant dose sparing.
    Ng HI; Fernando GJ; Depelsenaire AC; Kendall MA
    Sci Rep; 2016 Jul; 6():29368. PubMed ID: 27404789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous immunization: an evolving paradigm in influenza vaccines.
    Gill HS; Kang SM; Quan FS; Compans RW
    Expert Opin Drug Deliv; 2014 Apr; 11(4):615-27. PubMed ID: 24521050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch.
    Kim YC; Song JM; Lipatov AS; Choi SO; Lee JW; Donis RO; Compans RW; Kang SM; Prausnitz MR
    Eur J Pharm Biopharm; 2012 Jun; 81(2):239-47. PubMed ID: 22504442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity.
    Weldon WC; Martin MP; Zarnitsyn V; Wang B; Koutsonanos D; Skountzou I; Prausnitz MR; Compans RW
    Clin Vaccine Immunol; 2011 Apr; 18(4):647-54. PubMed ID: 21288996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial.
    Forster AH; Witham K; Depelsenaire ACI; Veitch M; Wells JW; Wheatley A; Pryor M; Lickliter JD; Francis B; Rockman S; Bodle J; Treasure P; Hickling J; Fernando GJP
    PLoS Med; 2020 Mar; 17(3):e1003024. PubMed ID: 32181756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of zymosan and poly (I:C) adjuvants on responses to microneedle immunization coated with whole inactivated influenza vaccine.
    Shin JH; Noh JY; Kim KH; Park JK; Lee JH; Jeong SD; Jung DY; Song CS; Kim YC
    J Control Release; 2017 Nov; 265():83-92. PubMed ID: 28890214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice.
    Pearson FE; McNeilly CL; Crichton ML; Primiero CA; Yukiko SR; Fernando GJ; Chen X; Gilbert SC; Hill AV; Kendall MA
    PLoS One; 2013; 8(7):e67888. PubMed ID: 23874462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles.
    Song JM; Kim YC; Barlow PG; Hossain MJ; Park KM; Donis RO; Prausnitz MR; Compans RW; Kang SM
    Antiviral Res; 2010 Nov; 88(2):244-7. PubMed ID: 20851715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.